Immage Biotherapeutics Intangible Assets

Immage Biotherapeutics posts a intangible assets of $5.7K as of February 2017. That compares with $5 in the prior-year period — up 114700.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Immage Biotherapeutics's intangible assets was $5. The latest reading is $5.7K — a 114700.0% year-over-year increase (period ending February 2017). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of Immage Biotherapeutics's financial statement story. At $5.7K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IMMG's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Immage Biotherapeutics's other metric pages and overview cover the third.